[HTML][HTML] A Self-Assembling Lipidic Peptide and Selective Partial V2 Receptor Agonist Inhibits Urine Production
S Patel, AB Volpe, S Awwad, AG Schätzlein… - Scientific Reports, 2020 - nature.com
Lipidised analgesic peptide prodrugs self-assemble into peptide nanofibers; with the
nanofiber morphology protecting the peptide from plasma degradation and improving …
nanofiber morphology protecting the peptide from plasma degradation and improving …
A Self-Assembling Lipidic Peptide and Selective Partial V2 Receptor Agonist Inhibits Urine Production
S Patel, AB Volpe, S Awwad, AG Schätzlein… - Scientific …, 2020 - ui.adsabs.harvard.edu
Lipidised analgesic peptide prodrugs self-assemble into peptide nanofibers; with the
nanofiber morphology protecting the peptide from plasma degradation and improving …
nanofiber morphology protecting the peptide from plasma degradation and improving …
A Self-Assembling Lipidic Peptide and Selective Partial V2 Receptor Agonist Inhibits Urine Production.
S Patel, AB Volpe, S Awwad, AG Schätzlein… - Scientific …, 2020 - discovery.ucl.ac.uk
Lipidised analgesic peptide prodrugs self-assemble into peptide nanofibers; with the
nanofiber morphology protecting the peptide from plasma degradation and improving …
nanofiber morphology protecting the peptide from plasma degradation and improving …
[HTML][HTML] A Self-Assembling Lipidic Peptide and Selective Partial V2 Receptor Agonist Inhibits Urine Production
S Patel, AB Volpe, S Awwad, AG Schätzlein… - Scientific …, 2020 - ncbi.nlm.nih.gov
Lipidised analgesic peptide prodrugs self-assemble into peptide nanofibers; with the
nanofiber morphology protecting the peptide from plasma degradation and improving …
nanofiber morphology protecting the peptide from plasma degradation and improving …
A Self-Assembling Lipidic Peptide and Selective Partial V2 Receptor Agonist Inhibits Urine Production.
S Patel, AB Volpe, S Awwad, AG Schätzlein… - Scientific …, 2020 - europepmc.org
Lipidised analgesic peptide prodrugs self-assemble into peptide nanofibers; with the
nanofiber morphology protecting the peptide from plasma degradation and improving …
nanofiber morphology protecting the peptide from plasma degradation and improving …
A Self-Assembling Lipidic Peptide and Selective Partial V2 Receptor Agonist Inhibits Urine Production
S Patel, AB Volpe, S Awwad… - Scientific …, 2020 - pubmed.ncbi.nlm.nih.gov
Lipidised analgesic peptide prodrugs self-assemble into peptide nanofibers; with the
nanofiber morphology protecting the peptide from plasma degradation and improving …
nanofiber morphology protecting the peptide from plasma degradation and improving …
A Self-Assembling Lipidic Peptide and Selective Partial V2 Receptor Agonist Inhibits Urine Production.
S Patel, AB Volpe, S Awwad, AG Schätzlein… - Scientific …, 2020 - search.ebscohost.com
Lipidised analgesic peptide prodrugs self-assemble into peptide nanofibers; with the
nanofiber morphology protecting the peptide from plasma degradation and improving …
nanofiber morphology protecting the peptide from plasma degradation and improving …
A Self-Assembling Lipidic Peptide and Selective Partial V2 Receptor Agonist Inhibits Urine Production.
S Patel, AB Volpe, S Awwad, AG Schätzlein… - Scientific …, 2020 - europepmc.org
Lipidised analgesic peptide prodrugs self-assemble into peptide nanofibers; with the
nanofiber morphology protecting the peptide from plasma degradation and improving …
nanofiber morphology protecting the peptide from plasma degradation and improving …